Intro
Preface
Contents
Chapter 1: Diversities of Various Nanomaterials-Based Vaccines for Healthcare Applications
1.1 Introduction
1.2 Role of Nanoparticles as Adjuvants in Vaccines
1.2.1 Nanoparticles in Vaccine
1.2.1.1 Nanoparticles as Adjuvants in Vaccines
1.2.2 Role of Metallic Nanoparticle
1.2.3 Carbohydrates Containing Nanoparticles as Vaccines
1.2.4 Polymer-Based Nanoparticles
1.2.5 Nanomaterial Vaccines
1.2.5.1 Concept of Nanomaterial-Based Vaccines
1.2.5.2 Current Market Scenario of Nanomaterial-Based Vaccines
1.2.6 Inorganic Nanoparticles

1.2.6.1 Liposomes
1.2.6.2 VLPs (Virus-Like Particles)
1.2.6.3 Dendrimers
1.3 Applications of Nanomaterials-Based Vaccines in Healthcare
1.4 Challenges in the Development of Nano-Based Vaccines
1.5 Future Perspectives
1.6 Conclusions
References
Chapter 2: Nanomedicine: Insight Analysis of Emerging Biomedical Research and Developments
2.1 Scope of Nanomedicine
2.1.1 Nanomedicine: R&D in Prophylaxis
2.1.2 Nanomedicine: R&D in Diagnostics
2.1.3 Nanomedicine in Therapeutics
2.1.3.1 Nanomedicine in Drug Delivery
2.1.3.1.1 Polymer-Based Nanoparticles

2.1.3.1.2 Lipid-Based NPs
2.1.3.1.3 Nonpolymeric Nanoparticles
2.2 Nanoparticles in Cancer Diagnosis
2.2.1 Nanoparticles in Bioimaging/Biosensing
2.2.2 Nanoparticles in Drug Delivery
2.3 Challenges in Nanomedicine R & D
2.4 Future Perspectives
References
Chapter 3: Nanomedicine: Therapeutic Approach of Vaccinology to Fight Against SARS/COVID-19
3.1 Detection of SARS/COVID-19
3.2 Diagnosis of SARS-CoV-2
3.2.1 Colorimetric
3.2.2 Biosensor
3.3 Types of Nanocarrier for Delivery of Drugs
3.3.1 Liposomes
3.3.2 Dendrimer
3.3.3 Polymer-Based Nanoparticles

3.3.4 Coating with PEG
3.3.5 Nanosuspension
3.3.6 Nanoemulsions
3.4 Conclusion
References
Chapter 4: Drug Delivery and Therapeutics for the Treatment of Infectious Diseases
4.1 Introduction
4.2 Conventional Drug Delivery and Therapeutics for Infectious Diseases
4.3 Drug Delivery Systems (DDS) to Combat Infectious Diseases
4.3.1 Polymer-Based Nanoparticulate Drug Delivery System
4.3.1.1 Dendrimers
4.3.1.2 Polymeric Micelles
4.3.1.3 Niosomes
4.3.1.4 Nanocapsules
4.3.1.5 Nanosphere
4.3.2 Lipid-Based NPs (LBNP)
4.3.2.1 Liposomes

4.3.2.2 Solid Lipid NPs (SLN)
4.3.2.3 Nanostructured Lipid Carriers (NLCs)
4.3.3 Metal-Based Nanoparticulate Drug Delivery System
4.3.3.1 Metal Colloids
4.3.3.2 Carbon Nanotubes
4.3.3.3 Fullerene
4.3.3.4 Gold Nanoshells
4.3.3.5 Silicone NPs
4.3.3.6 Quantum Dots
4.3.4 Biologicals
4.4 Biomimetic/Bioinspired Nano Therapies to Combat Infectious Diseases
4.4.1 Biomimetic NPs for Treatment
4.4.2 Biomimetic/Bioinspired NPs as Vaccines
4.5 Oral Nanobiotics: Delivery and Therapy for Infectious Diseases
4.5.1 Benefits of Nanoantibiotics